- Home
- SRE vs CAH Comparison
SRE vs CAH Comparison
Compare SRE & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRE | CAH |
|---|---|---|
| Founded | 1998 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Other Pharmaceuticals |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.6B | 55.6B |
| IPO Year | 2008 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SRE | CAH |
|---|---|---|
| Price | $84.83 | $238.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | $102.08 | ★ $232.27 |
| AVG Volume (30 Days) | ★ 3.2M | 1.9M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.84% | 1.01% |
| EPS Growth | N/A | ★ 12.09 |
| EPS | 1.58 | ★ 7.23 |
| Revenue | $13,702,000,000.00 | ★ $254,248,000,000.00 |
| Revenue This Year | $6.42 | $17.36 |
| Revenue Next Year | N/A | $9.06 |
| P/E Ratio | $53.18 | ★ $32.91 |
| Revenue Growth | 3.92 | ★ 14.23 |
| 52 Week Low | $80.46 | $145.87 |
| 52 Week High | $101.04 | $258.30 |
Technical Indicators
Market Signals| Indicator | SRE | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 59.41 |
| Support Level | N/A | $196.64 |
| Resistance Level | $96.22 | $243.21 |
| Average True Range (ATR) | 1.75 | 6.21 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 30.99 | 40.62 |
Price Performance
Historical ComparisonAbout SRE DBA Sempra
Sempra serves one of the largest utility customer bases in the United States. It distributes natural gas and electricity in Southern California and owns 80% of Oncor, a transmission and distribution business in Texas. Sempra Infrastructure Partners, 25% owned by Sempra, owns and operates liquefied natural gas facilities in North America and infrastructure in Mexico.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.